nervous
sodium
lead
pregnant
&gt
&gt &# n cardiovascular
&gt n cardiovascular
&lt
a cause
a decrease of g
a diuretic
a low value
a n
a n body as a whole
abdomen
Acetaminophen
acetazolamide
acute
addition of heparin
additionally
adults
Adverse reaction
adverse event
after subsequent injections
age
aicd discharge
Albumin
alcohol
all
all adverse experiences a
all adverse experiences a fumarate
all benzodiazepines
all body systems
all groups n
alone n
also
also seen
also seen at &gt
although
among racial groups
analgesics
anaphylactic
and
anf
ankle
anogenital regions
anticholinergic
antiemetics
antihistamines
antimitochondrial antibodies
antipyretics
anxiolytic
any dose n
any side effect
appearance
appendages
appendages disorder
appendages infrequent
applesauce
application site disorder
appropriate countermeasures
appropriate therapy instituted immediately
approximately to
as follows
at doses of
atenolol
atropine
attempt
atypical antipsychotic
available
axis deviation
b
back
barbiturates
benazepril n
beta-blocking
between elderly
Bicarbonate
biliary system disorder
black
blacks and non-blacks
blood
blood chemistry
blood chemistry analyses
body
body as a whole
body as a whole &# general disorder
body as a whole -
body system adverse experience
body system event
body system or
body system or adverse experience
body system or adverse experiences
body system or event
bone
both
Bromide
but
but not limited to
butnot limited to
by checklist
c n s reactions
can result in complications
cancer
capsule
capsules
carbamazepine
cardiac rhythm
cardio respiratory
cardiovascular
cardiovascular events
cardiovascular in the randomized comparison of metoprolol
cardiovascular system
cardiovascular system infrequent
carvedilol
central
central &amp
central &amp peripheral
characterized by rhythmical
che
chest
children
chlordiazepoxide
chlorpromazine
clcr
clcr in ml
clinical adverse experiences probably
clinical comparing timolol maleate
clinical laboratory findings
clinical pharmacology
clinically significant events
clomipramine n
clonazepam
clozapine
cns
cns reactions neuromuscular
cognitive dsyfunction speech
cognitive dysfunction alerted cognitive function
colon may be affected
colon problem
common
comparative agents
comparative agents n
comparative agents n with any side effect
comparison of gender
complaints
confirmed by rechallenge
conjunctival
continued
controlled
controlled s n incidence discontinuation
controlled s n incidence discontinuation weeks
conventional therapy plus
conventional therapy plus n
corpus luteum
cross
cross-sensitivity with desipramine
cutaneous
daily dose
day
day for up to
day of alprazolam
day of alprazolam tablets
days
decreased
decreased performance
definitely related
delayed onset of hit
delayed release tablets n
dental
dermatologic
dermatological
desaturation
diazepam
diazepam event
digestive
digestive lleus
digestive system
digestive system infrequent
discoloration
discontinuation
discontinuation body as a whole
discontinuation ets n
discontinuation hydrochloride tablets n
discontinuation weeks
discontinuations daily dose body system
discontinue the drug
discontinuing therapy
discussed above
disorder
disturbances
diuretics
dosage and administration
dose
dose dependent
dose related
dose-related
doses of
double-blind
dreaming
drug interaction
drug interactions
duration
duration of therapy
duration of treatment
during clinicals
during premarketing s
e g
each
ear
effect
effects
either reversible or irreversible
elderly and non-elderly
elevation
elevations
elicited
elicited foreign u s studies n
elicited foreign us studies
elicited foreign us studies n
ELISA
emotional
enalapril
enalapril maleate n incidence discontinuation
endocrine effects lactation
epigastric
especially in the elderly
especially narcotics
estazolam
Estrogen
etc
etiology
even years
event
events that
every h mild
every h moderate
every h severe
example
extracardiac
extremities
eye
eyes
face
Fasting
fatalities
feet
female
females
fetal
first
follows
for example
for immediate formulations
for immediate-release formulations
for the most part
foreign studies
four weeks
fourth weeks of treatment
frequency
frequent
from all
furthermore
gastrointestinal
gastrointestinal symptoms
gastrointestinal system
gastrointestinal system disorder
gastrointestinal sytem disorder
general
generally
genitourinary
genitourinary disorder
glottis
greater
greater than
greater than one year
greater than year
group receiving lamotrigine tablets
groups
groups by body system
gum
gums
have also been reported
have been reported
hcl n
hctz n incidence discontinuation
head
heart rate &lt beats or minute
heart rate or rhythm
heart rate rhythm
heat
hematologic
hematologic lymphatic systems
hematological disorder
hematologis
hematopoietic
hemic
hemic lymphatic
hemotologis
hepatobiliary tract
high dose n
high hematology
high less than hematology
higher
hodgkin
hour
however
hydrochlorothiazide
hydrochlorothiazide n incidenc e discontinuation
hydrochlorothiazide n incidence discontinuation
hypo-
i e
identified
idiosyncratic
iii
iii effects
immune system
immunologic in rare cases
incapacitating
incidence discontinuation
incidence incidence n
incidence of intervention because of symptom
incidence of or greater
included
increased
increases
indications
individuals
induced pseudo
infrequent
injection event
injection n a
innopran xl mg n
Insulin
integumentary system
intensification
intrafat
isis-
isoniazid
it was mild
ities abnormal
iv phenytoin adverseevent
jaw
joint
juices
keep patient lying down
kg dose group
kidneys
l in one
l in the other
l to iu
l to lu
labetalol hcl n
labetalol n
laboratory deviations
Laboratory test
laboratory tests
lamotrigine
language abnormalities speech abnormalities
larynx occurs
lens
less
less commonly reported
less frequently seen
less than
less than bpm
light
like other beta blockers
like other beta-blockers
lip
lips
lisinopril
listed by body system
listed by system
liver
long periods of therapy
long-term use
lorazepam
low
low dose n body as a whole
low high low high hematology
lungs
ly
lymphatic
lymphatic system
lymphatic system disorder very
lymphatic system infrequent
lymphatic systems
male
maleate
males
management
marketed levetiracetam
marketing experience
maximum daily dose &lt mg n
maximum daily dose all
may be dose-related
may occur
mcg
measles-like
mechanism of occurrence
mental
metabolic
metabolic abnormal lab value
metabolic nutritional
metabolic or nutritional
metabolism
metoprolol
metoprolol n body as a whole
metoprolol tartrate
mild
min
min needed
min rate
minor
miscellaneous complaints
ml min
months with carvedilol
more
more frequently with
more frequently with lisinopril
more severe reactions
mortality
mortality -
mouth or jaw
muscle
muscoloskeletal
musculoskeletal
musculoskeletal connective tissue
musculoskeletal system
myocardium
n =
n a
n body as a whole
n body as hyperlink whole
n by body system
n cardiovascular
n for male for female
n for male for female female
n gastrointestinal system
n incidenc e discontinuation
n incidence
n incidence body as a whole
n incidence discontinuation
n incidence discontinuation body as a whole
n incidence discontinuation weeks
n incidence discontinuation weeks body as whole
n n
n n body as a whole
n no gastrointestinal
n with any side effect
nasal
neuroleptic drugs
neurologic
neurological
neuromuscular
neuropsychiatric
neuropsychometrics
nlein purpura
non-blacks
non-elderly
none reported
nonetheless
nonspecific
normochromic
nose
not necessarily concurrently
not otherwise specified
not seen
number
numerically more frequent than
numerically more frequent than in the group
nutrition disorder
nutrition disorder very
nutritional
nutritional disorder
nutritional disorder infrequent
observe for at least
occasionally
occurred in about to
of one
of these
oid reactions
once weekly mg n
one
one-year
onset
or children
or of face
or psychiatric
oral
oral hypoglycemic agents
organophosphorus insecticides
organs
orthostatic
others
ovarian
over
over to minutes
overall
oxc n
pancreas
partial
participated in controlled clinicals
patient
patient-episodes
pediatric use
percent
perl
personality
pharynx
phenobarbital
phenytoin
place
platelet
potentially important
practolol
precautions
premorbid state abnormal
presumably a metabolite
primidone
progestin
prolonged
propranolol
propranolol n
protracted
pseudo
psychiatric
psychiatric disorder
quinidine-like effect
quinidinelike effect
race
randomized
rare
rarely
rarer
rate in a randomized
rate related
rbc
rbc hpf
rbc or hpf
reactions
reassurance
reassured
received oral sotalol
received since marketing
recovery
reduction
reflexes
reinfraction
related reactions
relatively short duration
renal
repiratory diseases
reported
reported in
reported infrequently
reports
reproduction disorder
reproductive
reproductive disorder &# female
reproductive system
required
respectively
respiration
respiratory
respiratory pulmonary problem
respiratory see w a r nings
respiratory system
respiratory system infrequent
respiratory thoracic
reversible
rhythm
rhythm disorder
rifampin
s disease
scalp
second
second or
secretion
secretion syndrome
sedative
see
seen at the
seen once are listed
sensitization
sensory
serious
serious dermatological reactions
serous membranes
severe
sex
short
short-term
should these occur
shown to be effective
significantly greater than
signs
signs increased
signs or symptoms
single instances of first-degree
skin
skin appendages
skin appendages disorder
soda or soda-like beverages
some are dose-related
some severe
sometimes fatal
special populations
special senses
special senses infrequent
special senses other
special senses visual problem
spo of
sporanox
standard meddra terminology
start antibiotic
start appropriate therapy
stop treatment
subcutaneous
subcutaneous tissue disorder very
sudden
sugar
suitable therapy
symptoms
system
system disorder
system neuromuscular
system or neuromuscular
systolic bp &lt mmhg
table
table enumerates the incidence
tablets low high low high hematology
tablets n
tabulations that follow
terbinafine hydrochloride tablets
terms not classifiable
the abuse
the cardiovascular system
the dosage of intravenous
the following
the following selected
the most common
the most common events
the most commonly observed
the most frequent reasons
the overall safety
the piperazine group
the safety
the signs
the skin
the thiazides
therapy should be discontinued
therefore
these sensations
these signs
they may be persistent
thioridazine
third
third trimester fetal
thirty
thoracic
throat
thus
tissues
to date
to mg n
to mg or day
to months
to years of age
tongue
total
total &# volunteered
total &# volunteered elicited foreign us studies
total - volunteered volunteered us studies
total volunteered
total volunteered volunteered us studies
transient
transient in nature
treatment
treatment regimen
trunk
tumor
two years duration
u s studies
units per infusion
unspecified
untoward event
untoward events enumerated above
up to
urinary
urinary disorder very
urinary system
urinary system disorder
urogenital
urogenital genitourinary
urogenital genitourinary disorder
urogenital system
urogenital system infrequent
urogenital system male
us studies
usp
usp in a double-blind
usually between the second
usually mild
usually mild to moderate
usually reversible
usually reversible q
usually self-limited
usually transient
valproate
valproic acid
vascular
vascular extracardiac disorder
versus
very
very important
vision
vol
vol percent
volunteered u s studies
volunteered u s studies total volunteered
volunteered us studies
volunteered us studies total volunteered
warnings
week
weeks body as a whole
weels body as a whole
when
when adverse reactions occur
when first observed
which
which are usually transient
while often mild
while the severity
who received
with all benzodiazepines
with discontinuation
with long-term use
withdrawn
within each category
within two weeks
women
years of age
